Literature DB >> 30396752

Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine.

Xin Wang1, Min Li1, Zhijie Lin2, Huirong Pan2, Zimin Tang1, Zizheng Zheng1, Shaowei Li3, Jun Zhang1, Ningshao Xia4, Qinjian Zhao5.   

Abstract

The integrity of functional epitopes is a critical quality attribute for recombinant protein based vaccines since the presence of these native-like epitopes is the structural basis for vaccines to elicit functional antibodies. To demonstrate the quality and quantity of functional epitopes on vaccine antigens, a toolbox of assessing antigen characteristics is essential. Among the physicochemical, biophysical, immunochemical and in vivo potency analyses, the epitope-specific assays are most critical assessment of the antigen functionality. In this study, we used hepatitis E virus vaccine as an example to illustrated how the monoclonal antibody (mAb) based immunochemical assays were established for in-depth and multifaceted antigen characterization. A large panel of mAbs were developed and characterized using epitope clustering analysis. A subset of these mAbs recognizing non-overlapping epitopes were chosen to be used for assay development. Orthogonal methods, including surface plasma resonance-based BIAcore, solution competitive ELISA and sandwich ELISA, were developed for the antigenicity assessment. The sandwich ELISA with a pair of mAbs, recognizing two different epitopes, was used to assess the accelerated antigen stability, showing enhanced stability with adjuvant adsorption. Such a sandwich ELISA with robust performance has the potentials to be used for in vitro potency analysis to replace animal-based potency assay as product release test. In summary, using hepatitis E vaccine as an example, we demonstrated the importance and establishment of a mAb-based immunochemical toolbox for multifaceted antigen characterization. This is particularly important to demonstrate the successful reconstruction of the native-like and functional epitopes on a recombinant antigen post expression and purification. These epitope-specific and multifaceted assays serve as critical tools for process monitoring or lot consistency tests in support of vaccine development and manufacturing.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30396752     DOI: 10.1016/j.vaccine.2018.10.089

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent.

Authors:  Bin He; Zhigang Zhang; Xinyuan Zhang; Zimin Tang; Chang Liu; Zizheng Zheng; Shaowei Li; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

2.  A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunity.

Authors:  Xin Wang; Xiaochen Yin; Boya Zhang; Chenfeng Liu; Yahua Lin; Xiaofen Huang; Yufang Li; Chenguang Shen; Weibin Zheng; Guofeng Fu; Junyu Chen; Yanling Wen; Wei Zhang; Bo-Sheng Pan; Mujin Fang; Zizheng Zheng; Zheng Zhang; Quan Yuan; Guo Fu; Shaowei Li; Jun Zhang; Yixin Chen; Ningshao Xia; Qinjian Zhao
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

Review 3.  Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation.

Authors:  Yike Li; Xiaofen Huang; Zhigang Zhang; Shaowei Li; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Viruses       Date:  2020-01-16       Impact factor: 5.048

4.  Identifying Circular RNAs in HepG2 Expressing Genotype IV Swine Hepatitis E Virus ORF3 Via Whole Genome Sequencing.

Authors:  Hanwei Jiao; Yu Zhao; Zhixiong Zhou; Wenjie Li; Bowen Li; Guojing Gu; Yichen Luo; Xuehong Shuai; Cailiang Fan; Li Wu; Jixuan Chen; Qingzhou Huang; Fengyang Wang; Juan Liu
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.